Literature DB >> 8937349

The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease.

T Gasser1, B Müller-Myhsok, A Supala, E Zimmer, G Wieditz, Z K Wszolek, P Vieregge, V Bonifati, W H Oertel.   

Abstract

The frequency of the CYP2D6B allele of the gene for debrisoquine 4-hydroxylase was studied in 115 patients with sporadic idiopathic Parkinson's disease, 55 of their healthy siblings, 63 patients with familial Parkinson's disease, 55 unaffected relatives, and 92 patients with Alzheimer's disease and 73 age matched healthy controls. By contrast with several previous studies, no significant variation of allele frequencies could be found between any of the groups studied. The results argue against a significant role of the CYP2D6 gene in the aetiology of sporadic and familial idiopathic parkinsonism in this patient population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8937349      PMCID: PMC1074052          DOI: 10.1136/jnnp.61.5.518

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.

Authors:  C A Smith; A C Gough; P N Leigh; B A Summers; A E Harding; D M Maraganore; S G Sturman; A H Schapira; A C Williams; D M Maranganore
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

2.  Research diagnostic criteria for Parkinson's disease.

Authors:  C D Ward; W R Gibb
Journal:  Adv Neurol       Date:  1990

3.  Association between the oxidative polymorphism and early onset of Parkinson's disease.

Authors:  J A Agúndez; F J Jiménez-Jiménez; A Luengo; M L Bernal; J A Molina; L Ayuso; A Vázquez; J Parra; J Duarte; F Coria
Journal:  Clin Pharmacol Ther       Date:  1995-03       Impact factor: 6.875

4.  Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease.

Authors:  M C Kurth; J H Kurth
Journal:  Am J Med Genet       Date:  1993-10-15

5.  Genotype relative risks: methods for design and analysis of candidate-gene association studies.

Authors:  D J Schaid; S S Sommer
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

6.  Associations of disease with genetic markers: déjà vu all over again.

Authors:  K K Kidd
Journal:  Am J Med Genet       Date:  1993-07-15

7.  Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.

Authors:  V Planté-Bordeneuve; M B Davis; D M Maraganore; C D Marsden; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

8.  Mutant debrisoquine hydroxylation genes in Parkinson's disease.

Authors:  M Armstrong; A K Daly; S Cholerton; D N Bateman; J R Idle
Journal:  Lancet       Date:  1992-04-25       Impact factor: 79.321

9.  Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes.

Authors:  T Gasser; Z K Wszolek; J Trofatter; L Ozelius; R J Uitti; C S Lee; J Gusella; R F Pfeiffer; D B Calne; X O Breakefield
Journal:  Ann Neurol       Date:  1994-09       Impact factor: 10.422

10.  CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.

Authors:  V Planté-Bordeneuve; O Bandmann; G Wenning; N P Quinn; S E Daniel; A E Harding
Journal:  Mov Disord       Date:  1995-05       Impact factor: 10.338

  10 in total
  1 in total

1.  CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis.

Authors:  Yu Lu; Cuiju Mo; Zhiyu Zeng; Siyuan Chen; Yantong Xie; Qiliu Peng; Yu He; Yan Deng; Jian Wang; Li Xie; Jie Zeng; Shan Li; Xue Qin
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.